Loading
CB
COSCIENS Biopharma Inc. Stock: price and insider trades · Canada
CA·Mcap CA$9.6M
COSCIENS Biopharma Inc.: what insiders have been doing
COSCIENS Biopharma Inc. is a listed company. Filings by its managers are published through SEDI. In the past year (18 October 2025 to 18 October 2026), 32 filings came from 9 insiders.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
For context, the typical company on the same exchange (median of 2,126 companies) published 12 filings over the same period, against 32 filings here.
Insider buying of COSCIENS Biopharma Inc. has been absent for the past year. Typically, a trade is published a median of 27 days after it takes place. Until a filing is published, the market cannot know about the trade.
Source: insider filings from SEDI. Past trades are no guide to future returns.
Insider Decl.
32
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 22,347 of 23,476 companies
15.6
score / 100
Value1
Quality30
FCF yld-100%
Earn yld-113%
EV/EBITDA·
ROE-53%
Gross mgn35%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CA$9.60
Analyst consensus
Income statement
RevenueCA$7.5M
Gross profitCA$2.6M35% margin
EBITDA-CA$9M-120% margin
Net income-CA$10.4M75.1% margin
Valuation
P/Book0.5x
Beta1.80
Balance sheet & cash
Market capCA$9.6M
Total debtCA$2.1M
Free Cash Flow-CA$9.2M
Debt / Equity13%
Profitability & ownership
ROE-52.8%
ROA-16.7%
% insiders27.5%
% institutions0.0%
Last declaration on 14 October 2026
Declarations32 total
Convertible Debentures 15% Unsecured due September 10, 2027TSXSEDI:4791108
Convertible Debentures 15% Unsecured due September 10, 2027TSXSEDI:4791091
@ €621.80Convertible Debentures 15% Unsecured due September 10, 2027TSXSEDI:4784057
Convertible Debentures 15% Unsecured due September 10, 2027TSXSEDI:4784056
@ €621.80Convertible Debentures 15% Unsecured due September 10, 2027TSXSEDI:4784050
Convertible Debentures 15% Unsecured due September 10, 2027TSXSEDI:4784035
@ €622.70Convertible Debentures 15% Unsecured due September 10, 2027TSXSEDI:4784019
Convertible Debentures 15% Unsecured due September 10, 2027TSXSEDI:4784002
@ €622.70Convertible Debentures 15% Unsecured due September 10, 2027TSXSEDI:4783982
Convertible Debentures 15% Unsecured due September 10, 2027TSXSEDI:4783856
11,000 sharesRestricted Share Units (RSU)TSXSEDI:4762922
Restricted Share Units (RSU)TSXSEDI:4762921
OptionsTSXSEDI:4762908
6,000 sharesDeferred Share UnitsTSXSEDI:4760209
Deferred Share UnitsTSXSEDI:4760200
6,000 sharesDeferred Share UnitsTSXSEDI:4758903
Deferred Share UnitsTSXSEDI:4758900
6,000 sharesDeferred Share UnitsTSXSEDI:4758898
Deferred Share UnitsTSXSEDI:4758896
6,000 sharesDeferred Share UnitsTSXSEDI:4758895
3,304 sharesOptionsTSXSEDI:4758893
10,000 sharesDeferred Share UnitsTSXSEDI:4758891
6,000 sharesDeferred Share UnitsTSXSEDI:4758887
3,304 sharesOptionsTSXSEDI:4758882
8,334 sharesDeferred Share UnitsTSXSEDI:4758878
25 of 32 declarations
About COSCIENS Biopharma Inc.
COSCIENS Biopharma Inc. is a biopharmaceutical company listed on the XTSE. It focuses on developing innovative treatments for various diseases.
